- $12.33bn
- $24.27bn
- $13.64bn
DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump (updated)
Brief: Berkshire Hathaway Inc Reports Open Market Sale Of 1,658,480 Davita's Common Shares On Jan 29 At $120.5561/Share
DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump
Brief: Davita announces 4Th Quarter 2025 Results
Brief: Davita Inc - On Nov 24, Entered Into Eighth Amendment To Credit Agreement Dated As Of August 12, 2019 - SEC Filing
U.S. RESEARCH ROUNDUP- Crowdstrike, Guardant Health, Palantir Technologies
Brief: Berkshire Hathaway sells 401,514 DaVita shares, still owns about 31.76 million
DaVita misses quarterly profit estimates on rising costs, lower volumes
Healthcare provider DaVita's Q3 revenue rises 4.8%
Brief: DaVita Q3 Revenue USD 3,420 Million Vs. IBES Estimate USD 3,428 Million
Ransomware attack at DaVita impacted 2.7 million people, US health dept website shows (updated)
Brief: HHS Says Davita Estimates Total Number Of Individuals Impacted By Cyberattack Is 2.7 Million
Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows
Brief: DaVita Boosts Share Repurchase Program By $2 Billion
DaVita Inc reports results for the quarter ended June 30 - Earnings Summary
DaVita beats quarterly profit on steady demand for dialysis services
Brief: Davita Enters Seventh Amendment To Credit Agreement
Factbox: Cyber threats disrupt global firms in US, UK and EU
Brief: Berkshire Hathaway Sold 200,000 DaVita Shares Between May 22 To May 27 For About $27.8 Million- SEC Filing